Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Multiple Sclerosis, Date of authorisa...
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Multiple Sclerosis, Date of authorisation: 08/01/2018, Revision: 14, Status: Authorised Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Multiple Sclerosis, Date of authorisation: 08/01/2018, Revision: 14, Status: Authorised geestelijk verzorger van GGZ NHN Jantien de Vries gaat voor in digi-viering over het rechte pad Human medicines European public assessment report (EPAR): Vaniqa, eflornithine, Hirsutism, Date of authorisation: 19/03/2001, Revision: 23, Status: Authorised Human medicines European public assessment report (EPAR): Vaniqa, eflornithine, Hirsutism, Date of authorisation: 19/03/2001, Revision: 23, Status: Authorised Actueel zorgnieuws i...